In the medical field, is the Biologics License Application (BLA) number for Kanuma (sebelipase alfa) .
The application was submitted by Alexion Pharmaceuticals and received FDA approval in September 2015 . Academic & Technical Research 125561
Another technical reference exists for "Deep fuzzy C-means clustering in a federated heterogeneous scenario," which uses a similar DOI sequence (10.1109/JAS.2025. 125561 ). Public Records & Evidence In the medical field, is the Biologics License
It is associated with a study on "Deep reinforcement learning for real-time energy dispatch in smart grids" published in the journal Applied Energy . 125561 )
It is an enzyme replacement therapy used to treat Lysosomal Acid Lipase (LAL) deficiency , a rare genetic condition.
A paper titled " Optimal nonparametric inference via deep neural network " is indexed under this number (Article 125561) in the Journal of Mathematical Analysis and Applications .
Under number 125561 , written evidence was submitted by Mrs. C. Roche to the UK Parliament regarding the impact of screen time and "digital drugs" on children’s brains and ADHD .